{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:11:09Z","timestamp":1775617869967,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":14,"publisher":"Springer US","isbn-type":[{"value":"9781071627716","type":"print"},{"value":"9781071627723","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_19","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"377-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Mesenchymal Stem Cells to Enhance the Efficacy of Gene Therapy"],"prefix":"10.1007","author":[{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L, Berry K, Church K et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377:1713\u20131722","journal-title":"N Engl J Med"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, Richman LK, Wilson JM (2018) Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther 29:285\u2013298","journal-title":"Hum Gene Ther"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1006\/mthe.2001.0491","volume":"4","author":"VR Arruda","year":"2001","unstructured":"Arruda VR, Fields PA, Milner R, Wainwright L, De Miguel MP, Donovan PJ, Herzog RW, Nichols TC, Biegel JA, Razavi M et al (2001) Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol Ther 4:586\u2013592","journal-title":"Mol Ther"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/mt.2009.56","volume":"17","author":"P Favaro","year":"2009","unstructured":"Favaro P, Downey HD, Zhou JS, Wright JF, Hauck B, Mingozzi F, High KA, Arruda VR (2009) Host and vector-dependent effects on the risk of germline transmission of AAV vectors. Mol Ther 17:1022\u20131030","journal-title":"Mol Ther"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ymthe.2004.07.025","volume":"10","author":"M Yoshimura","year":"2004","unstructured":"Yoshimura M, Sakamoto M, Ikemoto M, Mochizuki Y, Yuasa K, Miyagoe-Suzuki Y, Takeda S (2004) AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Mol Ther 10:821\u2013828","journal-title":"Mol Ther"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/sj.gt.3301829","volume":"9","author":"K Yuasa","year":"2002","unstructured":"Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, Tanouchi A, Yamamoto H, Li J, Chamberlain JS, Xiao X, Takeda S (2002) Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther 9:1576\u20131588","journal-title":"Gene Ther"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/mt.2011.154","volume":"19","author":"B Bostick","year":"2011","unstructured":"Bostick B, Shin JH, Yue Y, Duan D (2011) AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Mol Ther 19:1826\u20131832","journal-title":"Mol Ther"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/gt.2011.36","volume":"18","author":"JH Shin","year":"2011","unstructured":"Shin JH, Nitahara-Kasahara Y, Hayashita-Kinoh H, Ohshima-Hosoyama S, Kinoshita K, Chiyo T, Okada H, Okada T, Takeda S (2011) Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction. Gene Ther 18:910\u2013919","journal-title":"Gene Ther"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/mt.2008.225","volume":"17","author":"S Ohshima","year":"2009","unstructured":"Ohshima S, Shin JH, Yuasa K, Nishiyama A, Kira J, Okada T, Takeda S (2009) Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Mol Ther 17:73\u201380","journal-title":"Mol Ther"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/sj.gt.3302984","volume":"14","author":"K Yuasa","year":"2007","unstructured":"Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A, Hijikata T, Miyagoe-Suzuki Y, Takeda S (2007) Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Ther 14:1249\u20131260","journal-title":"Gene Ther"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","volume":"119","author":"J Zhu","year":"2009","unstructured":"Zhu J, Huang X, Yang Y (2009) The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest 119:2388\u20132398","journal-title":"J Clin Invest"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","volume":"363","author":"JR Mendell","year":"2010","unstructured":"Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G et al (2010) Dystrophin immunity in Duchenne\u2019s muscular dystrophy. N Engl J Med 363:1429\u20131437","journal-title":"N Engl J Med"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/mt.2015.5","volume":"23","author":"H Hayashita-Kinoh","year":"2015","unstructured":"Hayashita-Kinoh H, Yugeta N, Okada H, Nitahara-Kasahara Y, Chiyo T, Okada T, Takeda S (2015) Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance. Mol Ther 23:627\u2013637","journal-title":"Mol Ther"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2018.10.015","volume":"11","author":"T Tomono","year":"2018","unstructured":"Tomono T, Hirai Y, Okada H, Miyagawa Y, Adachi K, Sakamoto S, Kawano Y, Chono H, Mineno J, Ishii A et al (2018) Highly efficient ultracentrifugation-free chromatographic purification of recombinant AAV serotype 9. Mol Ther Method Clin Dev 11:180\u2013190","journal-title":"Mol Ther Method Clin Dev"}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:07:48Z","timestamp":1677654468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}